South and Central America Cell Therapy Bioprocessing Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Bioreactor, Lyophilization, Electrospinning, Control flow Centrifugation, Ultrasonic Lysis, Genome Editing Technology, Cell Immortalization Technology, and Viral Vector Technology); Cell Type (Stem Cell, Immune Cell, Human Embryonic Stem Cell, Pluripotent Stem Cell, and Hematopoietic Stem Cells), Indication (Cardiovascular Disease (CVD), Oncology, Wound Healing, Orthopaedic, and Others); End User (Hospitals and Clinics, Diagnostic Centres, Regenerative Medicine Centres, and Academic and Research Institute)

No. of Pages: 166    |    Report Code: TIPRE00024511    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South and Central America Cell Therapy Bioprocessing Market

TABLE OF CONTENTS

1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          Cell Therapy Bioprocessing Market – By Technology

1.3.2          Cell Therapy Bioprocessing Market – By Cell Type

1.3.3          Cell Therapy Bioprocessing Market – By Indication

1.3.4          Cell Therapy Bioprocessing Market – By End User

1.3.5          South and Central America Cell Therapy Bioprocessing Market – By Country

2.           South and Central America Cell Therapy Bioprocessing Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           South and Central America Cell Therapy Bioprocessing Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          Cell Therapy Bioprocessing Market- South and Central America PEST Analysis

4.3          Expert Opinion

5.           South and Central America Cell Therapy Bioprocessing Market - Key Market Dynamics

5.1          Market Drivers

5.1.1          Increasing Investments for Cell and Gene Therapy Manufacturing

5.1.2          Growing Approvals for Cell Therapies

5.2          Market Restraints

5.2.1          Challenges Associated with Cell Therapy Bioprocessing

5.3          Market Opportunities

5.3.1          Automated Procedures to Produce Cell Therapies

5.4          Future Trends

5.4.1          Digital Biomanufacturing

5.5          Impact Analysis

6.           Cell Therapy Bioprocessing Market – South and Central America Analysis

6.1          South and Central America Cell Therapy Bioprocessing Market Revenue Forecasts and Analysis

7.           South and Central America Cell Therapy Bioprocessing Market Analysis and Forecasts To 2028 – By Technology

7.1          Overview

7.2          Cell Therapy Bioprocessing Market Revenue Share, by Technology (2020 and 2028)

7.3          Bioreactor

7.3.1          Overview

7.3.2          Bioreactor: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.4          Lyophilization

7.4.1          Overview

7.4.2          Lyophilization: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.5          Electrospinning

7.5.1          Overview

7.5.2          Electrospinning: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.6          Control flow Centrifugation

7.6.1          Overview

7.6.2          Control flow Centrifugation: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028  (US$ Million)

7.7          Ultrasonic Lysis

7.7.1          Overview

7.7.2          Ultrasonic Lysis: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.8          Genome Editing Technology

7.8.1          Overview

7.8.2          Genome Editing Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.9          Cell Immortalization Technology

7.9.1          Overview

7.9.2          Cell Immortalization Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.10        Viral Vector Technology

7.10.1        Overview

7.10.2        Viral Vector Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

8.           Cell Therapy Bioprocessing Market Analysis – By Cell Type

8.1          Overview

8.2          Cell Therapy Bioprocessing Market Revenue Share, by Cell Type (2020 and 2028)

8.3          Stem Cell

8.3.1          Overview

8.3.2          Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

8.4          Immune Cell

8.4.1          Overview

8.4.2          Immune Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

8.5          Human Embryonic Stem Cell

8.5.1          Overview

8.5.2          Human Embryonic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

8.6          Pluripotent Stem Cell

8.6.1          Overview

8.6.2          Pluripotent Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

8.7          Hematopoietic Stem Cell

8.7.1          Overview

8.7.2          Hematopoietic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

9.           South and Central America Cell Therapy Bioprocessing Market Analysis and Forecasts To 2028 – By Indication

9.1          Overview

9.2          Cell Therapy Bioprocessing Market Revenue Share, by Indication (2020 and 2028)

9.3          Cardiovascular Disease (CVD)

9.3.1          Overview

9.3.2          Cardiovascular Disease (CVD): Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

9.4          Oncology

9.4.1          Overview

9.4.2          Oncology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

9.5          Wound Healing

9.5.1          Overview

9.5.2          Wound Healing: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

9.6          Orthopaedic

9.6.1          Overview

9.6.2          Orthopaedic: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

9.7          Others

9.7.1          Overview

9.7.2          Others: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

10.        South and Central America Cell Therapy Bioprocessing Market Analysis and Forecasts to 2028– By End User

10.1        Overview

10.2        Cell Therapy Bioprocessing Market Revenue Share, by End User (2020 and 2028)

10.3        Hospitals and Clinics

10.3.1        Overview

10.3.2        Hospitals and Clinics: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

10.4        Diagnostic Centres

10.4.1        Overview

10.4.2        Diagnostic Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

10.5        Regenerative Medicine Centres

10.5.1        Overview

10.5.2        Regenerative Medicine Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

10.6        Academic and Research Institute

10.6.1        Overview

10.6.2        Academic and Research Institute: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

11.        Cell Therapy Bioprocessing Market Revenue and Forecasts to 2028 – Geographical Analysis

11.1        South and Central America: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028

11.1.1        Overview

11.1.2        South and Central America: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

11.1.3        Brazil: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.1          Brazil: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.2          Brazil: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.1.3.3          Brazil: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.1.3.4          Brazil: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.1.3.5          Brazil: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.1.4        Argentina: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.4.1          Argentina: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.4.2          Argentina: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.1.4.3          Argentina: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.1.4.4          Argentina: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.1.4.5          Argentina: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.1.5        Rest of SCAM: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.5.1          Rest of SCAM: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.5.2          Rest of SCAM: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.1.5.3          Rest of SCAM: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.1.5.4          Rest of SCAM: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.1.5.5          Rest of SCAM: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

12.        Impact Of COVID-19 Pandemic on South and Central America Cell Therapy Bioprocessing Market

12.1        South and Central America: Impact Assessment of COVID-19 Pandemic

13.        Industry Landscape

13.1        Overview

13.2        Growth Strategies Done by the Companies in the Market, (%)

13.3        Organic Developments

13.3.1        Overview

13.4        Inorganic Developments

13.4.1        Overview

14.        COMPANY PROFILES

14.1        Fresenius Kabi AG

14.1.1        Key Facts

14.1.2        Business Description

14.1.3        Products and Services

14.1.4        Financial Overview

14.1.5        SWOT Analysis

14.1.6        Key Developments

14.2        Asahi Kasei Corporation

14.2.1        Key Facts

14.2.2        Business Description

14.2.3        Products and Services

14.2.4        Financial Overview

14.2.5        SWOT Analysis

14.2.6        Key Developments

14.3        Sartorius AG

14.3.1        Key Facts

14.3.2        Business Description

14.3.3        Products and Services

14.3.4        Financial Overview

14.3.5        SWOT Analysis

14.3.6        Key Developments

14.4        MERCK KGaA

14.4.1        Key Facts

14.4.2        Business Description

14.4.3        Products and Services

14.4.4        Financial Overview

14.4.5        SWOT Analysis

14.4.6        Key Developments

14.5        THERMO FISHER SCIENTIFIC INC.

14.5.1        Key Facts

14.5.2        Business Description

14.5.3        Products and Services

14.5.4        Financial Overview

14.5.5        SWOT Analysis

14.5.6        Key Developments

14.6        Corning Incorporated

14.6.1        Key Facts

14.6.2        Business Description

14.6.3        Products and Services

14.6.4        Financial Overview

14.6.5        SWOT Analysis

14.6.6        Key Developments

14.7        Cytiva

14.7.1        Key Facts

14.7.2        Business Description

14.7.3        Products and Services

14.7.4        Financial Overview

14.7.5        SWOT Analysis

14.7.6        Key Developments

14.8        Lonza

14.8.1        Key Facts

14.8.2        Business Description

14.8.3        Products and Services

14.8.4        Financial Overview

14.8.5        SWOT Analysis

14.8.6        Key Developments

14.9        Repligen

14.9.1        Key Facts

14.9.2        Business Description

14.9.3        Products and Services

14.9.4        Financial Overview

14.9.5        SWOT Analysis

14.9.6        Key Developments

14.10     Catalent Inc

14.10.1      Key Facts

14.10.2      Business Description

14.10.3      Products and Services

14.10.4      Financial Overview

14.10.5      SWOT Analysis

14.10.6      Key Developments

15.        Appendix

15.1        About the Insight Partners

15.2        Glossary of Terms


LIST OF TABLES

Table 1.              Brazil: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 2.              Brazil: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 3.              Brazil: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 4.              Brazil: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5.              Argentina: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 6.              Argentina: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 7.              Argentina: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 8.              Argentina: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9.              Rest of SCAM: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 10.            Rest of SCAM: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 11.            Rest of SCAM: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 12.            Rest of SCAM: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13.            Organic Developments Done By Companies

Table 14.            Inorganic Developments Done By Companies

Table 15.            Glossary of Terms, Cell Therapy Bioprocessing Market

 


LIST OF FIGURES

Figure 1.            Cell Therapy Bioprocessing Market Segmentation

Figure 2.            South and Central America Cell Therapy Bioprocessing Market Overview

Figure 3.            Bioreactor Segment Held Largest Share of Technology in Cell Therapy Bioprocessing Market

Figure 4.            Brazil is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.            Cell Therapy Bioprocessing Market - South and Central America PEST Analysis

Figure 6.            Cell Therapy Bioprocessing Market Impact Analysis of Driver and Restraints

Figure 7.            South and Central America Cell Therapy Bioprocessing Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8.            Cell Therapy Bioprocessing Market Revenue Share, by Technology (2020 and 2028)

Figure 9.            Bioreactor: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 10.          Lyophilization: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 11.          Electrodspinning: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12.          Control flow Centrifugation: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13.          Ultrasonic Lysis: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14.          Genome Editing Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15.          Cell Immortalization Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16.          Viral Vector Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.          Cell Therapy Bioprocessing Market Revenue Share, by Cell Type (2020 and 2028)

Figure 18.          Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 19.          Immune Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20.          Human Embryonic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21.          Pluripotent Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 22.          Hematopoietic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 23.          Cell Therapy Bioprocessing Market Revenue Share, by Indication (2020 and 2028)

Figure 24.          Cardiovascular Disease (CVD): Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 25.          Oncology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 26.          Wound Healing: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 27.          Orthopaedic: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 28.          Others: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 29.          Cell Therapy Bioprocessing Market Revenue Share, by End User (2020 and 2028)

Figure 30.          Hospitals and Clinics: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31.          Diagnostic Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32.          Regenerative Medicine Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33.          Academic and Research Institute: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 34.          South and Central America: Cell Therapy Bioprocessing Market, by Key Country – Revenue (2020) (USD Million)

Figure 35.          South and Central America: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

Figure 36.          Brazil: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 37.          Argentina: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 38.          Rest of SCAM: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 39.          Impact of COVID-19 Pandemic in South and Central America Country Markets

Figure 40.          Growth Strategies Done by the Companies in the Market, (%)

 

The List of Companies - South and Central America Cell Therapy Bioprocessing Market

  1. Fresenius Kabi Ag.
  2. Asahi Kasei Corporation
  3. Sartorius Ag
  4. Merck Kgaa
  5. Thermo Fisher Scientific Inc.
  6. Corning Incorporated
  7. Cytiva (Ge Healthcare)
  8. Lonza
  9. Repligen
  10. Catalent Inc